1,014
Views
12
CrossRef citations to date
0
Altmetric
Special Focus Commentary

Cancer vaccines and immunotherapeutics

Challenges for pricing, reimbursement and market access

&
Pages 1360-1363 | Received 18 Aug 2012, Accepted 21 Aug 2012, Published online: 24 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Ikponmwosa Osaghae, Onyema Greg Chido-Amajuoyi, Banda A. A. Khalifa & Sanjay Shete. (2023) Barriers and determinants of consistent offering of HPV vaccination by healthcare facilities. Human Vaccines & Immunotherapeutics 19:2.
Read now
Eddie J Gibson, Najida Begum, Ian Koblbauer, George Dranitsaris, Danny Liew, Phil McEwan, Yong Yuan, Ariadna Juarez-Garcia, David Tyas & Clive Pritchard. (2020) Economic Evaluation of Single versus Combination Immuno-Oncology Therapies: Application of a Novel Modelling Approach in Metastatic Melanoma. ClinicoEconomics and Outcomes Research 12, pages 241-252.
Read now
EJ Gibson, N Begum, I Koblbauer, G Dranitsaris, D Liew, P McEwan, AA Tahami Monfared, Y Yuan, A Juarez-Garcia, D Tyas & M Lees. (2018) Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes. ClinicoEconomics and Outcomes Research 10, pages 139-154.
Read now
Federica Cavallo, Luigi Aurisicchio, Rita Mancini & Gennaro Ciliberto. (2014) Xenogene vaccination in the therapy of cancer. Expert Opinion on Biological Therapy 14:10, pages 1427-1442.
Read now
Przemysław Holko & Paweł Kawalec. (2014) Economic evaluation of sipuleucel-T immunotherapy in castration-resistant prostate cancer. Expert Review of Anticancer Therapy 14:1, pages 63-73.
Read now

Articles from other publishers (7)

Luís Costa, Teresa Alexandre, André Mansinho, Rita Sousa, Cláudia Vieira, Robert Hughes, Alexander Roediger, Sónia Matos Pereira & António Araújo. (2023) Health outcomes and budget impact projection of anti-PD-(L)1s in cancer care in Portugal. Frontiers in Public Health 11.
Crossref
Jianxin Hu, Junfeng Hu, Xiandong Liu, Chao Hu, Ming Li & Wei Han. (2017) Effect and safety of cytokine-induced killer (CIK) cell immunotherapy in patients with breast cancer. Medicine 96:42, pages e8310.
Crossref
Maureen Banach & Jacques Robert. (2017) Tumor Immunology Viewed from Alternative Animal Models—the Xenopus Story. Current Pathobiology Reports 5:1, pages 49-56.
Crossref
Anand Rotte & Madhuri BhandaruAnand Rotte & Madhuri Bhandaru. 2016. Immunotherapy of Melanoma. Immunotherapy of Melanoma 419 434 .
Szymon Jarosławski & Mondher Toumi. (2015) Sipuleucel-T (Provenge®)—Autopsy of an Innovative Paradigm Change in Cancer Treatment: Why a Single-Product Biotech Company Failed to Capitalize on its Breakthrough Invention. BioDrugs 29:5, pages 301-307.
Crossref
Anand Rotte, Madhuri Bhandaru, Youwen Zhou & Kevin J. McElwee. (2015) Immunotherapy of melanoma: Present options and future promises. Cancer and Metastasis Reviews 34:1, pages 115-128.
Crossref
Kyle K. L. Phua, David Boczkowski, Jens Dannull, Scott Pruitt, Kam W. Leong & Smita K. Nair. (2013) Whole Blood Cells Loaded with Messenger RNA as an Anti‐Tumor Vaccine. Advanced Healthcare Materials 3:6, pages 837-842.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.